Abstract
PARP enzymes are involved in metabolic regulation and impact on a plethora of cellular metabolic pathways, among them, mitochondrial oxidative metabolism. The detrimental effects of PARP1 overactivation upon oxidative stress on mitochondrial oxidative metabolism was discovered in 1998. Since then, there was an enormous blooming in the understanding of the interplay between PARPs and mitochondria. Mitochondrial activity can be assessed by a comprehensive set of methods that we aim to introduce here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Virag L, Salzman AL, Szabo C (1998) Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161(7):3753–3759
Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ et al (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297(5579):259–263
Fatokun AA, Dawson VL, Dawson TM (2014) Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br J Pharmacol 171(8):2000–2016
DuBoff B, Feany M, Gotz J (2013) Why size matters – balancing mitochondrial dynamics in Alzheimer’s disease. Trends Neurosci 36(6):325–335
Wen Y, Li W, Poteet EC, Xie L, Tan C, Yan LJ et al (2011) Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem 286(18):16504–16515
Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145–1159
Adam-Vizi V, Chinopoulos C (2006) Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 27(12):639–645
Dagda RK (2019) Mito-morphology macro. https://imagejdocu.tudor.lu/plugin/morphology/mitochondrial_morphology_macro_plug-in/start. https://imagejdocu.tudor.lu/plugin/morphology/mitochondrial_morphology_macro_plug-in/start. Accessed 24 June 2020
Sprenger HG, Langer T (2019) The good and the bad of mitochondrial breakups. Trends Cell Biol 29(11):888–900. https://doi.org/10.1016/j.tcb.2019.08.003
Virag L, Szabo C (2000) BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic Biol Med 29(8):704–713
Bai P, Nagy L, Fodor T, Liaudet L, Pacher P (2015) Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol Metab 26(2):75–83
Sims JL, Berger SJ, Berger NA (1983) Poly(ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis. Biochemistry 22(22):5188–5194. https://doi.org/10.1021/bi00291a019
Chiarugi A (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci 23(3):122–129
Formentini L, Macchiarulo A, Cipriani G, Camaioni E, Rapizzi E, Pellicciari R et al (2009) Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure. J Biol Chem 284(26):17668–17676
Cantó C, Sauve A, Bai P (2013) Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Asp Med 34(6):1168–1201. https://doi.org/10.1016/j.mam.2013.01.004
Houtkooper RH, Canto C, Wanders RJ, Auwerx J (2010) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31(2):194–223
Brunyanszki A, Szczesny B, Virag L, Szabo C (2016) Mitochondrial poly(ADP-ribose) polymerase: the wizard of Oz at work. Free Radic Biol Med 100:257–270
Köritzer J, Blenn C, Bürkle A, Beneke S (2021) Mitochondria are devoid of poly(ADP-ribose)polymerase-1, but harbor its product oligo(ADP-ribose). J Cell Biochem 122(5):507–523. https://doi.org/10.1002/jcb.29887
Pirinen E, Cantó E, Jo SK, Morato L, Zhang H, Menzies KJ et al (2014) Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 19(6):1034–1041
Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Canto C et al (2013) The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154(2):430–441
Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G et al (2013) Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497(7450):451–457
Rodriguez-Vargas JM, Martin-Hernandez K, Wang W, Kunath N, Suganthan R, Amé JC et al (2020) Parp3 promotes astrocytic differentiation through a tight regulation of Nox4-induced ROS and mTorc2 activation. Cell Death Dis 11(11):954. https://doi.org/10.1038/s41419-020-03167-5
Yeh TY, Beiswenger KK, Li P, Bolin KE, Lee RM, Tsao TS et al (2009) Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 11:2476–2485
Wang H, Kuusela S, Rinnankoski-Tuikka R, Dumont V, Bouslama R, Ramadan UA et al (2020) Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1alpha PARylation in db/db mice. Int J Obes 44(8):1691–1702. https://doi.org/10.1038/s41366-020-0573-z
Marton J, Fodor T, Nagy L, Vida A, Kis G, Brunyanszki A et al (2018) PARP10 (ARTD10) modulates mitochondrial function. PLoS One 13(1):e0187789
Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C et al (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461–468. https://doi.org/10.1016/j.cmet.2011.03.004
Bai P, Canto C, Brunyánszki A, Huber A, Szántó M, Cen Y et al (2011) PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13(4):450–460. https://doi.org/10.1016/j.cmet.2011.03.013
Nagy L, Rauch B, Balla N, Ujlaki G, Kis G, Abdul-Rahman O et al (2019) Olaparib induces browning of in vitro cultures of human primary white adipocytes. Biochem Pharmacol 25(19):30250–20253
Mukhopadhyay P, Horvath B, Rajesh M, Varga ZV, Gariani K, Ryu D et al (2017) PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol 66(3):589–600
Cardinal JW, Allan DJ, Cameron DP (1999) Poly(ADP-ribose)polymerase activation determines strain sensitivity to streptozotocin-induced beta cell death in inbred mice. J Mol Endocrinol 22(1):65–70
Burkart V, Blaeser K, Kolb H (1999) Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor. Horm Metab Res 31(12):641–644
Bai P, Houten SM, Huber A, Schreiber V, Watanabe M, Kiss B et al (2007) Poly(ADP-ribose) polymerase-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome proliferator-activated receptor-gamma heterodimer. J Biol Chem 282(52):37738–37746
Szanto M, Rutkai I, Hegedus C, Czikora A, Rozsahegyi M, Kiss B et al (2011) Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovasc Res 92(3):430–438
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567):550–553
Fodor T, Szanto M, Abdul-Rahman O, Nagy L, Der A, Kiss B et al (2016) Combined treatment of MCF-7 cells with AICAR and methotrexate, arrests cell cycle and reverses Warburg metabolism through AMP-activated protein kinase (AMPK) and FOXO1. PLoS One 11(2):e0150232. https://doi.org/10.1371/journal.pone.0150232
Curtin NJ, Szabo C (2020) Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov 19(10):711–736. https://doi.org/10.1038/s41573-020-0076-6
Lee A (2021) Fuzuloparib: first approval. Drugs 81(10):1221–1226. https://doi.org/10.1007/s40265-021-01541-x
Markham A (2021) Pamiparib: first approval. Drugs 81(11):1343–1348. https://doi.org/10.1007/s40265-021-01552-8
Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG et al (2012) Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 30(3):283–288
Kovács I, Horváth M, Kovács T, Somogyi K, Tretter L, Geiszt M et al (2014) Comparison of proton channel, phagocyte oxidase, and respiratory burst levels between human eosinophil and neutrophil granulocytes. Free Radic Res 48(10):1190–1199. https://doi.org/10.3109/10715762.2014.938234
Kristof E, Klusoczki A, Veress R, Shaw A, Combi ZS, Varga K et al (2019) Interleukin-6 released from differentiating human beige adipocytes improves browning. Exp Cell Res 19(19):015
Hegedűs C, Juhász T, Fidrus E, Janka EA, Juhász G, Boros G et al (2021) Cyclobutane pyrimidine dimers from UVB exposure induce a hypermetabolic state in keratinocytes via mitochondrial oxidative stress. Redox Biol 38:101808. https://doi.org/10.1016/j.redox.2020.101808
Hegedűs C, Boros G, Fidrus E, Kis GN, Antal M, Juhász T et al (2020) PARP1 inhibition augments UVB-mediated mitochondrial changes – implications for UV-induced DNA repair and photocarcinogenesis. Cancers (Basel) 12(1):5. https://doi.org/10.3390/cancers12010005
Abdul-Rahman O, Kristof E, Doan-Xuan QM, Vida A, Nagy L, Horvath A et al (2016) AMP-activated kinase (AMPK) activation by AICAR in human white adipocytes derived from pericardial white adipose tissue stem cells induces a partial beige-like phenotype. PLoS One 11(6):e0157644
Marton J, Peter M, Balogh G, Bodi B, Vida A, Szanto M et al (2018) Poly(ADP-ribose) polymerase-2 is a lipid-modulated modulator of muscular lipid homeostasis. BBA-Mol Cell Biol L 1863(11):1399–1412. https://doi.org/10.1016/j.bbalip.2018.07.013
Szanto M, Brunyanszki A, Marton J, Vamosi G, Nagy L, Fodor T et al (2014) Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels. Biochim Biophys Acta 1842(4):594–602
Jankó L, Kovács T, Laczik M, Sári Z, Ujlaki G, Kis G et al (2021) Silencing of poly(ADP-ribose) polymerase-2 induces mitochondrial reactive species production and mitochondrial fragmentation. Cell 10(6):1387. https://doi.org/10.3390/cells10061387
Acknowledgments
The work was supported by grants from the NKFIH (K123975, K142141, FK128387, TKP2021-EGA-19, TKP2021-EGA-20). The Project no. TKP2021-EGA-19 and TKP2021-EGA-20 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the TKP2021-EGA funding scheme. The POST-COVID2021-33 grant to PB was from the Hungarian Academy of Sciences. EM is supported by the Bolyai Fellowship of the Hungarian Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kovács, T., Rauch, B., Mikó, E., Bai, P. (2023). Methods to Assess the Role of PARPs in Regulating Mitochondrial Oxidative Function. In: Tulin, A.V. (eds) Poly(ADP-Ribose) Polymerase. Methods in Molecular Biology, vol 2609. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2891-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2891-1_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2890-4
Online ISBN: 978-1-0716-2891-1
eBook Packages: Springer Protocols